| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Commercial Officer
1 company
Callos Andrew is an EVP, Chief Commercial Officer at CYTOKINETICS INC. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $5.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2025 | CYTK Cytokinetics Inc | EVP, Chief Commercial Officer | Sell | 2,775 | $44.38 | $123,154.50 | -7.4% | -24.8% | +38.3% | |
| Mar 17, 2025 | CYTK Cytokinetics Inc | EVP, Chief Commercial Officer | Sale+OE | 20,900 | $45.14 | $943,426.00 | -35.7% | -24.8% | +38.3% | |
| Mar 14, 2025 | CYTK Cytokinetics Inc | EVP, Chief Commercial Officer | Sale+OE | 100 | $45.00 | $4,500.00 | -0.3% | -25.2% | +35.4% | |
| Mar 13, 2025 | CYTK Cytokinetics Inc | EVP, Chief Commercial Officer | Sell | 26,771 | $43.62 | $1,167,751.02 | -41.5% | -25.4% | +35.3% | |
| Mar 6, 2025 | CYTK Cytokinetics Inc | EVP, Chief Commercial Officer | Sell | 3,341 | $43.27 | $144,565.07 | -4.9% | -25.1% | +39.6% | |
| Mar 3, 2025 | CYTK Cytokinetics Inc | EVP, Chief Commercial Officer | Sell | 1,114 | $42.88 | $47,768.32 | -1.6% | -27.2% | +41.5% |